6.28
2.94%
-0.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BCRX Giù?
Forum
Previsione
Biocryst Pharmaceuticals Inc. Borsa (BCRX) Ultime notizie
New York State Common Retirement Fund Sells 17821 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World
Defense World
Is the Options Market Predicting a Spike in BioCryst Pharmaceuticals (BCRX) Stock? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
BioCryst Pharmaceuticals Shares Rise 20% Following Disclosure of Executive Share Purchases - Marketscreener.com
Marketscreener.com
Biocryst Pharmaceuticals exec buys $164k in company stock - Investing.com Canada
Investing.com Canada
Biocryst Pharmaceuticals CEO buys $166,500 in company stock By Investing.com - Investing.com Australia
Investing.com Australia
Biocryst Pharmaceuticals director buys $120k in stock By Investing.com - Investing.com Australia
Investing.com Australia
Biocryst Pharmaceuticals executive buys $27,650 in stock By Investing.com - Investing.com Australia
Investing.com Australia
BioCryst Pharmaceuticals CFO buys $202k in company stock - Investing.com Australia
Investing.com Australia
Biocryst Pharmaceuticals executive buys $27,650 in stock By Investing.com - Investing.com Canada
Investing.com Canada
Biocryst Pharmaceuticals CEO buys $166,500 in company stock By Investing.com - Investing.com Canada
Investing.com Canada
Steven K. Galson Purchases 21,940 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Stock - MarketBeat
MarketBeat
Biocryst Pharmaceuticals exec buys $164k in company stock - Investing.com
Investing.com
BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap Up Following Insider Buying Activity - MarketBeat
MarketBeat
Insider Buying: Chief R&D Officer Helen Thackray Acquires 30000 Shares of BioCryst ... - Yahoo Finance
Yahoo Finance
Director Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX) - Yahoo Finance
Yahoo Finance
Insider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX) - Yahoo Finance
Yahoo Finance
Insider Buying: CFO Anthony Doyle Acquires Shares of BioCryst Pharmaceuticals Inc (BCRX) - Yahoo Finance
Yahoo Finance
BioCryst stock spikes on insider purchases (NASDAQ:BCRX) - Seeking Alpha
Seeking Alpha
Biocryst Pharmaceuticals executive buys $27,650 in stock By Investing.com - Investing.com
Investing.com
Biocryst Pharmaceuticals CFO purchases $202k in company stock - Investing.com
Investing.com
BioCryst Pharmaceuticals CFO buys $202k in company stock - Investing.com
Investing.com
Biocryst Pharmaceuticals CFO purchases $202k in company stock - Investing.com UK
Investing.com UK
Biocryst Pharmaceuticals director buys $120k in stock By Investing.com - Investing.com UK
Investing.com UK
Biocryst Pharmaceuticals executive buys $27,650 in stock By Investing.com - Investing.com UK
Investing.com UK
Biocryst Pharmaceuticals CEO buys $166,500 in company stock By Investing.com - Investing.com UK
Investing.com UK
Biocryst Pharmaceuticals exec buys $164k in company stock - Investing.com UK
Investing.com UK
What Kind Of Shareholders Hold The Majority In BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) Shares? - Yahoo New Zealand News
Yahoo New Zealand News
BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology - GlobeNewswire
GlobeNewswire
BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology
GlobeNewswire Inc.
Mexico approves BioCryst's HAE drug ORLADEYO - Investing.com India
Investing.com India
BioCryst Pharmaceuticals (BCRX) in Focus: Stock Moves 8.5% Higher - Yahoo Movies UK
Yahoo Movies UK
BioCryst (BCRX) Provides Updates on Galidesivir, Shares Fall - Yahoo Singapore News
Yahoo Singapore News
Is the Options Market Predicting a Spike in BioCryst Pharmaceuticals (BCRX) Stock? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Mexico approves BioCryst's HAE drug ORLADEYO By Investing.com - Investing.com
Investing.com
Mexico approves BioCryst's HAE drug ORLADEYO By Investing.com - Investing.com UK
Investing.com UK
ORLADEYO® (berotralstat) Approved in Mexico - GlobeNewswire
GlobeNewswire
ORLADEYO® (berotralstat) Approved in Mexico - Yahoo Finance
Yahoo Finance
Are Institutions Heavily Invested In BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) Shares? - Yahoo News UK
Yahoo News UK
Los Angeles Capital Management LLC Has $319000 Stock Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World
Defense World
BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) institutional shareholders had a great week as one-year returns ... - Yahoo Canada Shine On
Yahoo Canada Shine On
BioCryst Pharmaceuticals, Inc. to Post Q2 2024 Earnings of ($0.14) Per Share, HC Wainwright Forecasts (NASDAQ ... - Defense World
Defense World
Research Analysts Issue Forecasts for BioCryst Pharmaceuticals, Inc.'s Q2 2024 Earnings (NASDAQ:BCRX) - MarketBeat
MarketBeat
BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization ... - GlobeNewswire
GlobeNewswire
Analysts Are Updating Their BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Estimates After Its First-Quarter Results - Yahoo Finance
Yahoo Finance
FY2028 EPS Estimates for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Reduced by Analyst - Defense World
Defense World
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Forecasted to Earn FY2028 Earnings of $1.31 Per Share - MarketBeat
MarketBeat
BioCryst Pharmaceuticals (NASDAQ:BCRX) Given New $15.00 Price Target at JMP Securities - Defense World
Defense World
BioCryst Pharmaceuticals (NASDAQ:BCRX) Receives Buy Rating from Needham & Company LLC - Defense World
Defense World
BioCryst Pharmaceuticals (NASDAQ:BCRX) Issues Earnings Results - MarketBeat
MarketBeat
BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Up 5.5% on Strong Earnings - MarketBeat
MarketBeat
Capitalizzazione:
|
Volume (24 ore):